23andmeaduhelmaheadaialarmingalnylamalzheimeramgenanotherapprovalascoastrazenecabadbidenbigbiobiogenbiotechbirdblockbusterblockbustersboldboombrainbreakthroughbusinesscaliffcancercarecasecdccellceoceoschinachinesecomecontroversialcontroversycoronaviruscovidcrisiscrisprcurecutsdatadaydealdealmakingdebatabledebatedeepdilemmadiseasednadramadrugdrugseditingeffectsendeveryexperimentfakefaucifdafirstfluftcfundingfuturegenegeneticgenomegeorgegetgileadglpgoldgottliebhealthhistoryholmeshothypeilluminaindustryinsideinsiderinsulinintrigueipojpmjrkidslatestlayoffslegacylegallifelillylivelonglooklossmarketmeansmedicalmedicinemerckmergermessymicrobiomemidtermsmilestonemodernamrnanewsnextnihnobelnomineenovartisnovavaxobesityomicronopioidpandemicpatientspfizerpharmapillspivotplanplansplightpluspotentialpreviewpricespricingpromisepublicquestraceredrememberingreportresearchresponsereturnreviewrfkriserisksrushsagasareptasciencescottsetbackshkrelishortagesstarstartupstartupsstatstocksstorystudysuccesssuccessionsummitsurgesurprisetakestechtheranostherapiestherapytradingtreatmenttrialtrialstrumpturntwitterupheavalvaccinevaccinesvcvcsvertexweekwegovyweightwinterworldwrongyear